Dollars and Digital: The Future of Pharma Finance
New Flare-Up in Europe's External Reference Pricing Debate
It’s Time for a Chief Adherence Officer
Adopting New Technology: Barriers and Breakthroughs
Survey Spotlights the CFO’s Strategic Rise
FDA After Gottlieb: Thorny Issues, Political Challenges
Easing the Path to Profitability
A Strategic Approach to Pharma R&D Portfolio Planning
Pharmaceutical Executive, May 2019 Issue (PDF)